“…Being mostly focused on bioavailability and bioequivalency, the reported assays describe quantitative determination of CPZ in biological fluids such as breast milk 19, plasma 20, and middle ear fluid 21, 22, and in some pharmaceutical preparations such as tablets 23, 24 and oral suspensions 25. Within the methods used to determine CPZ, LC with MS 26–28 or UV 19, 20, 22, 24–25, 28–31 detection was popular. Among these, MS detection shows its superiority over UV detection in terms of specificity and detection limits because of unique capabilities such as multiple and selected reaction monitoring.…”